Search

Your search keyword '"Hao D"' showing total 94 results

Search Constraints

Start Over You searched for: Author "Hao D" Remove constraint Author: "Hao D" Publisher elsevier bv Remove constraint Publisher: elsevier bv
94 results on '"Hao D"'

Search Results

1. Predictors of COVID-19 Infection and Hospitalization in Group Homes for Individuals with Intellectual and/or Developmental Disabilities

4. Adjusting solar-induced fluorescence to nadir-viewing provides a better proxy for GPP

7. Fabrication of AgI/Ce-2MI Z-scheme heterojunction for enhanced photoreduction of Cr(VI) under visible light irradiation

8. Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial

11. EP10.01-008 Examining Social Determinants of Health Among Newly Diagnosed Lung Cancer Patients Contacted for Early Specialist Palliative Care Consultation

12. EP04.02-004 The Patient Impact of Liquid Biopsy - Health-Related Quality of Life in Patients Undergoing Liquid Biopsy for Advanced Non-Small Cell Lung Cancer

14. Practical approaches for normalizing directional solar-induced fluorescence to a standard viewing geometry

17. OA16.02 The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer

21. 904P ACCURACY: A phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut): Results of 6-mg cohort

27. P89.03 Demonstrating VALUE of Liquid Biopsy for Lung Cancer in a Public Healthcare System

28. Coupling iron pretreatment with a constructed wetland-microbial fuel cell to improve wastewater purification and bioelectricity generation

34. 1195P The value of detecting resistance through liquid biopsy

35. IgG Fc glycosylation as an axis of humoral immunity in childhood

44. Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND.226 study of durvalumab ± tremelimumab in combination with platinum-doublet chemotherapy

45. MA11.04 Platinum Doublet + Durvalumab +/- Tremelimumab in Patients with Advanced NSCLC: A CCTG Phase IB Study - IND.226

48. Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study

Catalog

Books, media, physical & digital resources